T-cell receptor (TcR) recombinations can be recovered from tumor specimen, whole exome sequences (WXS) files. However, it
Characterizing recombinations, N-region amino acids, and V(D)J usage of TcRs in tissue resident T-cells is an important goal for a variety of types of studies and for medical purposes. For example, recombined TcR genes can reveal the presence of a/b and g/d T-cells and predict cytokine expression in the micro-environment; and recombined TcRs offer the hope of providing guidance on designing chimeric antigen receptor Tcells that are based on TcR V(D)J recombiations rather than immunoglobulin genes. 1 Obtaining tissue resident TcR V(D)J recombinations has generally been limited to disaggregation of tissue, isolation of T-cells, and targeted sequencing of TcR genes. 2 More recently, it has been demonstrated that, using TcR specific exon capture approaches, it is possible to identify specific TcR V(D)J recombinations without the separation of T-cells from tissue. 3 However, it is also become clear that TcR V(D)J recombinations can be detected in standard exome (WXS) files representing tumor specimens, originally intended for identification of tumor mutations. [4] [5] [6] This approach represents a considerable technical advance over more complicated approaches, for several reasons. First, to date there are likely between 500,000 and one million WXS representing TcR V(D)J recombinations and V(D)J usages, allowing a vast data collection to be mined for preliminary and perhaps fundamental information regarding the connection of specific TcRs to pathological conditions and single nucleotide polymorphisms. Second, the widespread access to the WXS pipeline makes the opportunity to assess TcR V(D)J recombinations available in a very wide variety of medical and research settings at relatively low cost, particularly research projects involving large numbers of patients.
To better characterize the potential role, impact, and usefulness of TcR V(D)J recombinations as determined by analyses of bulk tissue WXS, we examined the TcR recombinations and V(D)J usage in melanoma WXS available through TCGA and in mouse WXS. Results indicate that TcR recombinations detectable in tissue representing a pathological lesion are related to an antigen-based immune response; and that both productive and nonproductive V(D)J recombinations can be detected in the tumor microenvironment.
Material and Methods

Processing the human WXS files
The nucleotide sequences for both V regions and J regions of human and mouse TcR were collected from NCBI, and additional allele sequences were obtained from IMGT/GENE -DB. 7 The V and J sequences are listed in the Electronic Supporting Information (ESM). Whole exome sequences (WXS) of primary and metastatic melanoma were collected from the Cancer Genome Atlas (TCGA; SKCM), using a key file provided for dbGaP approved project number 6300. To identify candidate V region sequences in the WXS files, the SearchV script, in the ESM 4 was used for each TCR gene. The SearchV script contained a list of unduplicated sequences close to the 3 0 end of the V regions. The V regions sequences used were five nucleotides away from the 3 0 end of the V sequence to avoid losses in the search due to N-region diversity. Candidate V-regions recovered from the WXS files were deposited into a TSV file. The SearchJ script (ESM) 4 was then used to search the V region TSV outputs for exact nucleotide matches to the J sequences. The J sequences identified as an exact match to sequence reads in the candidate V files were deposited into a TSV file. Both the candidate V files and the J files were then the object of the script, IMGTSearchTCR.php (ESM), as follows. The J regions listed in the TSV files were used to search the candidate V files (i.e., the V files that are matched to the J output files by barcode). This process recovers the read that has the VJ combination. IMGTSearchTCR.php then interrogates the IMGT tool for determining whether the reads are productive or unproductive.
Obtaining and processing the mouse WXS files
You and colleagues 8 reported development of melanomas in a mouse model driven by loss of Pten and Cdkn2a (Ink4a/Arf). Specifically, 3 out of 46 Pten1/2; Cdkn2a (Ink4a/Arf) -/-mice (6.5%) developed melanomas at 28-31 weeks of age. For this report, we studied melanomas that developed in Pten 
RNASeq data
The RNASeq z-scores for the genes indicated in Results were processed essentially as described in Ref. 9 and obtained from cBioPortal. 10, 11 The RNASeq z-scores are detailed for each barcode in the ESM.
Results
To obtain an initial picture of the TcR gene recombinations present in melanoma, as detected by analysis of melanoma WXS files, we searched the TCGA SKCM WXS files for TcRa, -b, -g, -d recombinations for 99 primary and 307 metastatic samples, which revealed several features (Table 1) . First, both productive and unproductive reads can be detected in the WXS files for all of the TcR genes. Second, the a/b TcR recombinations are much more common in the melanoma WXS files than are the g/d TcR recombinations. Third, the percentage of samples representing a/b T-cells is somewhat increased when comparing primary and metastatic samples, What's new? T-cell receptor (TcR) recombinations have been identified in tumor lymphocytes. However, it has not been clear how these recombinations relate to the anti-tumor immune response. In this study, the authors developed an algorithm to analyze TcR recombinations using standard tumor exome (WXS) files. Further analysis found unusual types of TcR recombination in the files, and also revealed that the anti-tumor response in melanoma may be blunted by expression of the immune-checkpoint protein PD-1. This algorithm may allow an enhanced understanding of lymphocytes that impact tumor development, in both humans and mice. 
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particularly in the case of T-cells represented by the recombination of the TcR-a gene. The very high level of TcR-a recombination is consistent with the understanding that many T-cells undergo the recombination of both TcR-a alleles. Finally, the ratio of barcodes with productive versus unproductive recombinations is significantly higher for the TcR-b gene, for both primary and metastatic samples (Fig. 1a ).
TcR-a gene recombinations and VJ usage in several SKCM samples have been described previously. 4 The collection of the productive and unproductive recombination reads, and the VJ usage, for the TcR-a gene recombinations represented by the primary samples is in Supporting Information Table S1 in the ESM.
This report is the first report of TcR-b gene recombinations in a melanoma WXS file. The productive recombinations for the primary samples of Table 1 are provided in detail in Table 2 ; several examples of the TcR-b recombinations, with the N-region nucleotides and the VDJ usage are shown in Figure 1b . As indicated in Table 1 , of the 99 primary samples, 19 represented productive, TcR-b recombinations. Of these 19, 4 samples represented more than one detected, productive read. In all 4 of these samples, only two different productive TcR-b recombinations were identified, that is, no sample represented the detection of more than two different TcR-b, productive recombinations. Overall, the results for the primary samples indicated V and J usage variety. The metastatic samples revealed some additional V and J usage, however, the number of metastatic samples was much higher. Thus, there is no statistically significant difference in the V and J usage patterns for primary and metastatic samples apparent at this time.
The ratio of TcR-b productive to unproductive recombinations is much higher than are the analogous ratios for the TcR-a and TcR-g genes (Fig. 1a) , indicating that the formation of the antigen binding site reflected in WXS detectable TcR recombinations is limited by the TcR-b VDJ recombination. This is also the first report of TcR-g and -d recombinations in any WXS files, with the reads representing the productive recombinations indicated in Table 3 and Figures  1c and 1d .
To determine whether the above approach of identifying TcR recombinations and V(D)J usage could be subject to laboratory, experimental approaches, we generated WXS from three mouse melanoma and three mouse normal tissue samples and searched the WXS files for mouse TcR-a, -b, -g, and -d. Results indicated only one, unproductive TcR-a and one unproductive -g in each of the three mouse melanoma samples. However, productive TcR-b and -g recombinations were detected in the normal tissue, WXS files (ESM, Supporting Information Tables S2 and S3) .
Finally, to determine whether the co-detection of productive TcR-a and productive TcR-b recombinations correlated with other immune activity in the tumor specimen, we obtained the RNASeq z scores values for each of the barcodes representing: (i) co-detection of productive TcR-a and productive TcR-b recombinations; (ii) detection of productive TcR-a recombinations but no detection of TcR-b recombinations; (iii) detection of productive TcR-b recombinations but no detection of TcR-a recombinations; and (iv) detection of unproductive TcR-a recombinations but no detection of productive a or b recombinatios ( Table 4 ). The latter three sets of barcodes were effectively control sets for the first collection of barcodes representing co-detection of productive TcR-a and productive TcR-b recombinations in a given barcode. Only the barcodes representing the metastatic SKCM samples were used due to a lack of sufficient numbers of primary SKCM barcodes for statistical analyses. The RNASeq z-scores for the following genes were compared across the above barcode groups: CD274 (PD-L1), PDCD1 (PD-1), CTLA4, CIITA, CD33, CD68, CD83, ITGAX, CTSL, CTSS and IFNG. In no case was a p < 0.05 obtained for CD274 RNASeq z-scores when comparing barcodes representing co-detection of productive TcR-a and productive TcR-b recombinations with the above indicated control sets, although in two cases the p values were just above 0.05 (ESM). No significant p-values were obtained for the RNASeq z-scores represented by CTLA4 12 ; the dendritic cell marker represented by CD83; or the antigen processing protease, represented by CTSL 13 (ESM). However, results did indicate a strong association of expression of the T-cell, programmed cell death receptor gene, PDCD1, 12, 14 and codetection of productive TcR-a and productive TcR-b recombinations (Table 4) . And, there was a strong association of expression of the MHCII transcriptional coactivator, CIITA, 15 with co-detection of productive TcR-a and productive TcR-b recombinations. There was also a correlation of the neutrophil marker, CD33, 16 and the macrophage marker, CD68, 17 along with the antigen processing protease CTSS, [18] [19] [20] with co-detection of productive TcR-a and productive TcR-b recombinations (Table 4 ).
Discussion
The above results further support initial conclusions that micro-environment cells, in addition to tumor cells, can be assessed genetically in tumor specimen WXS files. Specifically, in addition to previously reported detection of TcR-a VJ recombinations in WXS files, 4 and TcR-b recombinations (without detailed, productive or unproductive characterizations) in RNASeq files, 6 this work verifies the opportunity to detect recombinations for all three of the other TcR genes, particularly the recombinations resulting from the genes that undergo recombination less frequently than TcR-a. In fact, the relative rate of detection of the different TcR gene recombinations plays a role in establishing the basic validity of the approach of assessing TcR recombinations in tumor WXS files. That is, the relative rate of detection of the a/b recombination events mirrors the expectations based on the understanding of the dual allele, TcR-a recombinations. 21 And, the relatively low-level detection of g/d recombinations would be expected based on the relatively lower numbers of g/d T-cells in most settings. Finally, the productive TcR-g recombinations are more numerous than the productive TcR-d recombinations, reflecting the expectation of relative abundance of these recombinations based on the parallels with the a/b recombination rates and based on the simple issue of probability: as with TcR-a, only one "successful" recombination event is required to generate a productive TcR-g chain, whereas two successful recombination events would be required for a successful VDJ formation of the TcR-b and -d genes.
The ratio of productive to unproductive TcR-b recombinations is relatively high. While there has been indications that a fixed TcR-a can lead to a robust T-cell response dependent on the diversity of the available TcR-b VDJ recombinations, 22 there are also data indicating the extensive role of the TcR-a chain in binding to antigenic, MHC bound peptide. 23 However, the high ratio of productive to unproductive TcR-b VDJ recombinations does suggest that there is a selection for the productive TcR-b recombinations and that these recombinations, therefore, represent an indicator of antigen affinity. This possibility would have to be confirmed by additional studies, but if this is the case, the presence of the productive TcR-b chain, as detected in conventional WXS files, would be a biomarker of melanoma tumor immunogenicity.
Follow up RNASeq analyses of the barcodes that represent the co-detection of productive recombinations for both TcRa and -b indicated that these barcodes have a tendency ? Finally, the opportunities to detect both productive and unproductive recombinations hold the prospect of stratifying patient tumors in that both of these recombinations likely indicate the presence of either a/b or g/d T-cells and indicate micro-environment conditions, such as cytokine expression, that impact tumor growth. And keeping in mind the previously noted, big data opportunities, the detection of both productive and unproductive recombinations will likely allow a better understanding of the association of V(D)J usage with HLA types, 25 specific mutations 26 or mutation rates. [27] [28] [29] [30] Although the mouse WXS data above is very limited, most likely owing to the very limited numbers of samples examined, the results do indicate unproductive recombinations in mouse melanoma WXS, again, emphasizing the opportunity to evaluate T-cell impacts on tumor growth independently of antigen presentation.
